Sierra Summit Advisors »

Theravance Biopharma shares owned by Sierra Summit Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Sierra Summit Advisors from 13F filings

Historical chart of Sierra Summit Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Sierra Summit Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Sierra Summit Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 59k 18.71

More positions owned by Sierra Summit Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ge Vernova (GEV)
Citigroup Com New (C)
Rocket Cos Com Cl A (RKT)
Eli Lilly & Co. (LLY)
Astera Labs (ALAB)
Robinhood Mkts Com Cl A (HOOD)
First Solar (FSLR)
Hldgs (UAL)
Amazon (AMZN)
Shopify Cl A Sub Vtg Shs (SHOP)
Vertiv Holdings Com Cl A (VRT)

View all positions for Sierra Summit Advisors

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma